Drug profile

The FDA adverse-event record for Canine Rabies Vaccine

233 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Canine Rabies Vaccine. See the species affected, top reactions, and outcomes below.

233
adverse-event reports
11.2%
death-coded share
Dog
most-reported species
84
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
233
Total Reports
26
Deaths Reported
11.2%
Death Rate

Active Ingredients

Canine Rabies Vaccine

Administration Routes

UnknownSubcutaneous

Species Affected

Dog 225
Cat 8

Most Affected Breeds

Retriever - Labrador 32
Chihuahua 23
Terrier - Yorkshire 11
Terrier - Bull - American Pit 11
Boxer (German Boxer) 10
Bulldog - French 8
Retriever - Golden 7
Terrier - Boston 5
Shepherd Dog - German 5
Siberian Husky 5

Most Reported Reactions

Vomiting 84
Lethargy (see also Central nervous system depression in 'Neurological') 60
Facial swelling (see also 'Skin') 49
Hives (see also 'Skin') 47
Diarrhoea 28
Anaphylaxis 26
Fever 22
Pale mucous membrane 20
Seizure NOS 18
Anorexia 18
Ataxia 13
Emesis 13

Outcome Breakdown

Ongoing
107 (45.9%)
Recovered/Normal
86 (36.9%)
Died
14 (6.0%)
Outcome Unknown
13 (5.6%)
Euthanized
12 (5.2%)
Recovered with Sequela
1 (0.4%)

Canine Rabies Vaccine Adverse Event Insights

233 reports name Canine Rabies Vaccine; 26 recorded a death outcome (11.2% of reported events, not a population-level mortality rate). Active ingredient: Canine Rabies Vaccine. Administration routes: Unknown, Subcutaneous.

By species: Dog (225 reports), Cat (8 reports). By breed: Retriever - Labrador (32), Chihuahua (23), Terrier - Yorkshire (11).

Leading clinical signs: Vomiting (84), Lethargy (see also Central nervous system depression in 'Neurological') (60), Facial swelling (see also 'Skin') (49), Hives (see also 'Skin') (47). Outcome, 233 coded reports: Ongoing leads at 45.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.